Come up with a name for your new list and we'll add to it:
AmideBio raised a round of funding on September 28, 2017. Investors include
National Institutes of Health.
AmideBio is a biotechnology company focused on providing peptide and protein research reagents and clinical products for a diverse array of research and commercial targets. AmideBio addresses the chal…